Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

J. P. Clancy, L. Dupont, M. W. Konstan, J. Billings, S. Fustik, C. H. Goss, J. Lymp, P. Minic, A. L. Quittner, R. C. Rubenstein, K. R. Young, L. Saiman, J. L. Burns, J. R.W. Govan, B. Ramsey, R. Gupta

Research output: Contribution to journal › Article › peer-review

223 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science